LBA43 Intradermal IMO-2125 versus placebo as adjuvant treatment in patients with stage II pT3-4/cN0 melanoma: Interim efficacy and safety results of the randomized phase II INTRIM study.
Saved in:
| Title: | LBA43 Intradermal IMO-2125 versus placebo as adjuvant treatment in patients with stage II pT3-4/cN0 melanoma: Interim efficacy and safety results of the randomized phase II INTRIM study. |
|---|---|
| Authors: | Notohardjo, J.C.L.1 (AUTHOR), Veenstra, S.1 (AUTHOR), Koster, B.D.1 (AUTHOR), Kandiah, V.1 (AUTHOR), van der Velde, S.2 (AUTHOR), Francken, A.B.3 (AUTHOR), Gooiker, G.A.4 (AUTHOR), van den Tol, M.P.2 (AUTHOR), Bekkenk, M.W.5 (AUTHOR), Hof, K.H. in 't6 (AUTHOR), Straver, M.E.7 (AUTHOR), Molenkamp, B.G.8 (AUTHOR), Vuylsteke, R.J.C.L.M.9 (AUTHOR), Lissenberg-Witte, B.I.10 (AUTHOR), Labots, M.1 (AUTHOR), Chunduru, S.K.11 (AUTHOR), van Akkooi, A.C.J.12 (AUTHOR), Van Den Eertwegh, F.1 (AUTHOR), de Gruijl, T.D.1 (AUTHOR) |
| Source: | Annals of Oncology. 2022 Supplement 7, Vol. 33, pS1410-S1410. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 159078743 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: LBA43 Intradermal IMO-2125 versus placebo as adjuvant treatment in patients with stage II pT3-4/cN0 melanoma: Interim efficacy and safety results of the randomized phase II INTRIM study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Notohardjo%2C+J%2EC%2EL%2E%22">Notohardjo, J.C.L.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Veenstra%2C+S%2E%22">Veenstra, S.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Koster%2C+B%2ED%2E%22">Koster, B.D.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kandiah%2C+V%2E%22">Kandiah, V.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22van+der+Velde%2C+S%2E%22">van der Velde, S.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Francken%2C+A%2EB%2E%22">Francken, A.B.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gooiker%2C+G%2EA%2E%22">Gooiker, G.A.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22van+den+Tol%2C+M%2EP%2E%22">van den Tol, M.P.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bekkenk%2C+M%2EW%2E%22">Bekkenk, M.W.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hof%2C+K%2EH%2E+in+'t%22">Hof, K.H. in 't</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Straver%2C+M%2EE%2E%22">Straver, M.E.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Molenkamp%2C+B%2EG%2E%22">Molenkamp, B.G.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Vuylsteke%2C+R%2EJ%2EC%2EL%2EM%2E%22">Vuylsteke, R.J.C.L.M.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lissenberg-Witte%2C+B%2EI%2E%22">Lissenberg-Witte, B.I.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Labots%2C+M%2E%22">Labots, M.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chunduru%2C+S%2EK%2E%22">Chunduru, S.K.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22van+Akkooi%2C+A%2EC%2EJ%2E%22">van Akkooi, A.C.J.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Van+Den+Eertwegh%2C+F%2E%22">Van Den Eertwegh, F.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22de+Gruijl%2C+T%2ED%2E%22">de Gruijl, T.D.</searchLink><relatesTo>1</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2022 Supplement 7, Vol. 33, pS1410-S1410. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=159078743 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2022.08.042 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: S1410 Titles: – TitleFull: LBA43 Intradermal IMO-2125 versus placebo as adjuvant treatment in patients with stage II pT3-4/cN0 melanoma: Interim efficacy and safety results of the randomized phase II INTRIM study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Notohardjo, J.C.L. – PersonEntity: Name: NameFull: Veenstra, S. – PersonEntity: Name: NameFull: Koster, B.D. – PersonEntity: Name: NameFull: Kandiah, V. – PersonEntity: Name: NameFull: van der Velde, S. – PersonEntity: Name: NameFull: Francken, A.B. – PersonEntity: Name: NameFull: Gooiker, G.A. – PersonEntity: Name: NameFull: van den Tol, M.P. – PersonEntity: Name: NameFull: Bekkenk, M.W. – PersonEntity: Name: NameFull: Hof, K.H. in 't – PersonEntity: Name: NameFull: Straver, M.E. – PersonEntity: Name: NameFull: Molenkamp, B.G. – PersonEntity: Name: NameFull: Vuylsteke, R.J.C.L.M. – PersonEntity: Name: NameFull: Lissenberg-Witte, B.I. – PersonEntity: Name: NameFull: Labots, M. – PersonEntity: Name: NameFull: Chunduru, S.K. – PersonEntity: Name: NameFull: van Akkooi, A.C.J. – PersonEntity: Name: NameFull: Van Den Eertwegh, F. – PersonEntity: Name: NameFull: de Gruijl, T.D. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2022 Supplement 7 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 33 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
